Journal Mobile Options
Table of Contents
Vol. 75, No. 2, 2006
Issue release date: February 2006
Psychother Psychosom 2006;75:72–84

Specificity of Cognitive Deficits in Bipolar Disorder versus Schizophrenia

A Systematic Review

Daban C. · Martinez-Aran A. · Torrent C. · Tabarés-Seisdedos R. · Balanzá-Martínez V. · Salazar-Fraile J. · Selva-Vera G. · Vieta E.
aBipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, and bTeaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, Valencia, Spain

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: More and more epidemiological, genetic and neuroimaging studies show similarities between bipolar disorder (BD) and schizophrenia (SZ). Cognitive functions are known to be highly impaired in SZ and are increasingly studied in BD. When both populations are compared, the conclusions appear to be contradictory. The purpose of this review is to help define the profile of cognitive deficits in BD and in SZ. Methods: A systematic review of the literature of neuropsychological studies comparing BD and SZ was made, beginning in January 1990 and ending in January 2005. Thirty-eight studies met the required quality criteria and were included in this review. Results: Bipolar patients exhibit extensive cognitive abnormalities with a pattern of deficits that is not unique to this disease. However, when compared to schizophrenic patients, bipolar patients demonstrate a lesser degree of deficits, particularly concerning premorbid and current intelligence quotient and perhaps attention, verbal memory and executive functions. When looking into effect sizes, there seem to be different profiles even in studies finding no significant differences. Conclusions: The neuropsychological differences reported between both groups could be due to the presence of psychotic features, to environmental factors (stressful events, duration of the disease and number of hospitalisations) and could also be related to differences during the neurodevelopmental phase. Further studies should confirm whether these results are truly related to different neurobiological backgrounds.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, Nahon D, Davidson M: Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry 2001;58:959–964.
  2. Faraone SV, Kremen WS, Tsuang MT: Genetic transmission of major affective disorders: quantitative models and linkage analyses. Psychol Bull 1990;108:109–127.
  3. Möller HJ: Bipolar disorder and schizophrenia: distinct illness or a continuum? J Clin Psychiatry 2003;64:23–27.
  4. Maier W, Rietschel M, Lichtermann D, Wildenauer DB: Family and genetic studies on the relationship of schizophrenia to affective disorders. Eur Arch Psychiatry Clin Neurosci 1999;249:57–61.
  5. Tkachev D, Mimmack M, Ryan M, Wayland M, Freeman T, Jones PB, Starkey M, Webster M, Yolken R, Bahn S: Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003;362:798–805.
  6. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME: MRI anatomy of schizophrenia. Biol Psychiatry 1999;45:1099–1119.
  7. Rubinsztein J, Fletcher PC, Rogers RD, Ho LW, Aigbirhio F, Paykel ES, Robbins TW, Sahakian BJ: Decision-making in mania: a PET-study. Brain 2001;124:2550–2563.
  8. Soares JC, Mann JJ: The anatomy of mood disorders: review of structural neuroimaging studies. Biol Psychiatry 1997;41:86–106.
  9. Berrettini WH: Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000;48:531–538.
  10. Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Gasto C, Salamero M: Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000;69:2–18.
  11. Bearden CE, Hoffman KM, Cannon TD: The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disord 2001;3:151–153.

    External Resources

  12. Dhingra U, Rabins PV: Mania in the elderly: a 5–7 year follow-up. J Am Geriatr Soc 1991;39:581–583.
  13. Spitzer RL, Williams JB, Gibbon M, First M: User’s Guide for the Structured Clinical Interview for DSMIII-R (SCID). Washington, American Psychiatric Press, 1990.
  14. First M, Spitzer R, Gibbon M, Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, American Psychiatric Press, 1997.
  15. Kay S, Fiszbein A, Opler L: The positive and negative syndrome scale for schizophrenia (PANSS). Schizophr Bull 1987;13:261–276.
  16. Young RC, Biggs JT, Ziegler V, Meyer D: A rating scale for mania: reliability, validity and sensibility. Br J Psychiatry 1978;113:429–435.
  17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  18. Purdon SE: Measuring neuropsychological change in schizophrenia with novel antipsychotic medications. J Psychiatry Neurosci 2000;25:108–116.
  19. MacQueen G, Young T: Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disord 2003;5:53–61.
  20. Shi L, Namjoshi MA, Zhang F, Gandhi G, Edgell ET, Tohen M, Breier A, Haro JM: Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int J Psychopharmacol 2002;17:227–237.
  21. Reinares M, Martinez-Aran A, Colom F, Benabarre A, Salamero M, Vieta E: Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients. Acta Esp Psiquiatr 2000;28:231–238.
  22. Rollnik JD, Borsutszy M, Hubert T, Moghk H, Seifert J, Emrich H, Scheinder U: Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics. Neuropsychobiology 2002;45:74–80.
  23. Meyer-Lindenberg A, Gruppe H, Bauer H, Lis S, Krieger S, Gallhoffer B: Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: a result from a double-blind study. Pharmacopsychology 1997;30:35–42.
  24. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S: The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003;64:86–93.
  25. Honig A, Arts B, Ponds R, Riedel W: Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999;14:167–171.
  26. Stip E, Dufresne J, Lussier I, Yatham L: A double-blind placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Affect Disord 2000;60:147–157.
  27. Meador K, Roning D, Ray P, Murro A, King M, Perrine K, Vasquez B, Kiolbaso T: Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;56:1177–1182.
  28. Goldberg JF, Burdick KE: Cognitive side effects of anticonvulsants. J Clin Psychiatry 2001;62:27–33.
  29. Nickel T, Sonntag A, Zihl J, Holsboer F: Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol 2003;23:155–158.
  30. Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Mahli G, Gonzalez-Pinto A, Daban C, Alvarez-Grandi S, Fountoulakis K, Krapinis G, Tabares-Seisdedos R, Ayuso-Mateos JL: Functional outcome in bipolar disorder: the role of clinical and cognitive factors and medication. Bipolar Disord, in press.
  31. Atre-Vaidya N, Taylor M, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F: Cognitive deficits, psychopathology and psychosocial functioning in bipolar mood disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:120–126.
  32. Martinez-Aran A, Vieta E, Colom F, Torrent C, Sanchez-Moreno J, Goikolea JM, Benabarre A, Brugue E, Daban C, Salamero M: Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004;6:224–232.
  33. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321–330.
  34. Martinez-Aran A, Penadés M, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gasto C: Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2002;71:39–46.
  35. Dickerson F, Sommerville J, Origoni A, Ringel N, Parente F: Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning. Psychiatry Res 2001;102:21–27.
  36. Wechsler D: Wechsler Adult Intelligence Scale Revised. Cleveland, Psychological Corporation, 1981.
  37. Souza V, Muir W, Walter M, Glabus M, Roxborough H, Sharp C, Dunan J, Blackwood D: Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol Psychiatry 1995;37:300–310.
  38. Morice R: Cognitive inflexibility and prefrontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990;157:50–54.
  39. Seidman LJ, Kremen WS, Koren D, Faraone SV, Goldstein J, Tsuang MT: A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr Res 2002;53:31–44.
  40. Seidman LJ, Lanca M, Kremen WS, Faraone SV, Tsuang MT: Organization and visual memory deficits in schizophrenia and bipolar psychoses using Rey-Osterrieth complex figure: effects of duration of illness. J Clin Exp Neuropsychol 2003;25:949–964.
  41. Goldberg TE, Gold JM, Greenberg R: Contrasts between patients with affective disorder and patients with schizophrenia on a neuropsychological battery. Am J Psychiatry 1993;150:1355–1362.
  42. Hobart MP, Goldberg R, Bartko JJ, Gold JM: Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia. 2. Convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999;156:1951–1957.
  43. Gard D, Harrell EH, Poreh A: Cognitive deficits in schizophrenia on the WAIS-R NI Sentence Arrangement Subtest. Wechsler Adult Intelligence Scale-Revised Neuropsychological Inventory. J Clin Psychol 1999;55:1085–1094.
  44. Zalla T, Joyce C, Szoke A, Schurhoff F, Pillon B, Komano O, Perez-Diaz F, Bellivier F, Alter C, Dubois B, Rouillon F, Houde O, Leboyer M: Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004;121:207–217.
  45. Nelson H, Willison J: National Adult Reading Scale, ed 2. Windsor, NFER-Nelson, 1991.
  46. McGrath J, Scheldt S, Welham J, Clair A: Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases. Schizophr Res 1997;26:127–137.
  47. McGrath J, Chapple B, Wright M: Working memory in schizophrenia and mania: correlation with symptoms during the acute and subacute phases. Acta Psychiatr Scand 2001;103:181–188.
  48. Jastak JF, Jastak S: Wide Range Achievement Test – Revised. Wilmington, Jastak Associates, 1985.
  49. Jones PB, Bebbington P, Foerster A, Lewis SW, Murray RM, Russell A, Sham PC, Toone BK, Wilkins S: Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993;162:65–71.
  50. Gilvarry C, Takei N, Russell A, Rushe T, Hemsley D, Murray R: Premorbid IQ in patients with functional psychosis and their first-degree relatives. Schizophr Res 2000;41:417–429.
  51. Altshuler L, Ventura J, Van Gorp W, Green MF, Theberge DC, Mintz J: Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004;56:560–569.
  52. Balanzà-Martinez V, Tabarès-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, Leal-Cercos C, Vieta E, Gomez-Beneyto M: Persistent cognitive dysfunction in bipolar I and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005;74:113–119.
  53. Hoff AL, Shukla S, Aronson T, Cook B, Ollo C, Baruch S, Jandorf L, Schwartz J: Failure to differentiate bipolar disorder from schizophrenia on measures of neuropsychological function. Schizophr Res 1990;3:253–260.
  54. Motjabai R, Bromet E, Harvey PD, Carlson G, Craig T, Fennig S: Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. Am J Psychiatry 2000;157:1453–1460.
  55. Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, Murray RM: Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry 1997;154:1544–1550.
  56. Reichenberg A, Weiser M, Caspi A, Schmeidler J, M Mark, Kaplan Z, Davidson M: A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder and nonpsychotic bipolar disorder. Am J Psychiatry 2002;159:2027–2035.
  57. Zammit S, Allebeck P, David A, Dalman C: A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression and other nonaffective psychoses. Arch Gen Psychiatry 2004;61:354–360.
  58. Cannon M, Caspi A, Moffitt T, Harrington HL, Taylor A, Murray R, Poulton R: Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder. Arch Gen Psychiatry 2002;59:449–456.
  59. Rund BR, Orbeck AL, Landro NI: Vigilance deficits in schizophrenics and affectively disturbed patients. Acta Psychiatr Scand 1992;86:207–212.
  60. Docherty NM, Hawkins KA, Hoffman RE, Quinlan DM, Rakfeldt J, Sledge WH: Working memory, attention, and communication disturbances in schizophrenia. J Abnorm Psychol 1996;105:212–219.
  61. Addington J, Addington D: Attentional vulnerability indicators in schizophrenia and bipolar disorder. Schizophr Res 1997;23:197–204.
  62. Tam WC, Sewell K, Deng H: Information processing in schizophrenia and bipolar disorder: a discriminant analysis. J Nerv Ment Dis 1998;186:597–603.
  63. Tam WC, Liu Z: Comparison of neurocognition between drug-free patients with schizophrenia and bipolar disorder. J Nerv Ment Dis 2004;192:464–470.
  64. Liu S, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen WJ: Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 2002;159:975–982.
  65. Albus M, Hubmann W, Wahlheim, Sobizack N, Franz U, Mohr F: Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 1996;94:87–93.
  66. Ferrier I, Stanton B, Kelly T, Scott J: Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999;175:246–251.
  67. Rubinsztein J, Michael A, Paykel E, Sahakian B: Cognitive impairment in remission bipolar affective disorder. Psychol Med 2000;30:1025–1036.
  68. Golden CJ: Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Wood Dale, Stoeling Co, 1978.
  69. Krabbendaum L, Honig A, Wiersma J, Vuurman E, Hofman P, Derix M, Nolen W, Jolles J: Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000;101:274–280.
  70. Verdoux H, Liraud F: Neuropsychological function in subjects with psychotic and affective disorders. Relationship to diagnostic category and duration of illness. Eur Psychiatry 2000;15:236–243.
  71. Basso MR, Nasrallah HA, Olson S, Bornstein R: Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophr Res 1998;31:99–111.
  72. Grant I, Gonzalez R, Carey C, Natarajan L, Wolfson T: Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol Soc 2003;9:679–689.
  73. Delis DC, Kramer J, Kaplan E, Ober B: California Verbal Learning Test Manual. New York, Psychological Corporation, 1987.
  74. Wechsler D: The Wechsler Memory Scale, ed. 3. San Antonio, Psychological Corp Harcourt, 1997.
  75. Tompkins LM, Goldman RS, Axelrod BN: Modifiability of neuropsychological dysfunction in schizophrenia. Biol Psychiatry 1995;38:105–111.
  76. Landro NI, Orbeck AL, Rund BR: Memory functioning in chronic and non-chronic schizophrenics, affectively disturbed patients and normal controls. Schizophr Res 1993;10:85–92.
  77. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH: Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance of the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res 2004;129:45–53.
  78. Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benabarre A, Goikolea J, Comes M, Salamero M: Cognitive function across manic or hypomanic, depressed and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262–270.
  79. Heaton RK: The Wisconsin Card Sorting Test Manual. Odessa, Psychological Assessment Resource, 1981.
  80. Wagman A, Wagman W: On the Wisconsin; in Walker E, Dworkin R, Cornblatt B (eds): Progress in Experimental Personality and Psychopathology Research. New York, Springer, 1992.
  81. Metz JT, Johnson MD, Pliskin NH, Luchins DJ: Maintenance of training effects on the Wisconsin Card Sorting Test by patients with schizophrenia or affective disorder. Am J Psychiatry 1994;151:120–122.
  82. Young DA, Zakzanis KK, Bailey C, Davila R, Griese J, Sartory G, Thom A: Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease. J Nerv Ment Dis 1998;186:44–50.
  83. Zihl J, Gron G, Brunnauer A: Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 1998;97:351–357.
  84. Rossi A, Arduini L, Daneluzzo E, Bustini M, Prosperini P, Stratta P: Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients and healthy controls. J Psychiatr Res 2000;34:333–339.
  85. Arduini L, Kalyvoka A, Statta P, Rinaldi O, Daneluzzo E, Rossi A: Insight and neuropsychological function in patients with schizophrenia and bipolar disorder with psychotic features. Can J Psychiatry 2003;48:338–341.

    External Resources

  86. Reitan RM: Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271–276.

    External Resources

  87. Hawkins KA, Hoffman R, Quilan D, Rakfeld J, Docherty N, Sledge W: Cognition, negative symptoms and diagnosis: a comparison of schizophrenic, bipolar and control samples. J Neuropsychiatry Clin Neurosci 1997;9:81–89.
  88. Green MF, Nuechterlein KH, Mintz J: Backward masking in schizophrenia and mania. 1. Specifying a mechanism. Arch Gen Psychiatry 1994;51:939–944.
  89. Gooding D, Tallent K: The association between antisaccade task and working memory performance in schizophrenia and bipolar disorder. J Nerv Ment Dis 2001;189:8–16.
  90. Carter CS, Perlstein W, Ganguli R, Brar J, Mintum M, Cohen JD: Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998;155:1285–1287.
  91. Barch DM, Sheline YI, Csernansky JG, Snyder AZ: Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry 2003;53:376–384.
  92. Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SC, Sharma T, Murray RM, McGuire PK: Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J Affect Disord 2001;66:111–121.
  93. Zubieta JK, Huguelet P, O’Neil RL, Giordani BJ: Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001;102:9–20.
  94. Rund BR: A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998;24:425–435.
  95. Kelly J, Murray R: What risk factors tell us about the causes of schizophrenia and related psychoses. Curr Psychiatry Rep 2000;2:378–385.
  96. Mehler C, Warnke A: Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging studies. J Neural Transm 2002;109:219–234.
  97. Franke P, Maier W, Hain C, Klinger T: Wisconsin Card Sorting Test: an indicator of vulnerability of schizophrenia? Schizophr Res 1992;6:243–249.
  98. Cornblatt B, Malhotra A: Impaired attention as an endophenotype for molecular genetic studies. Am J Med Genet 2001;105:11–15.
  99. MacQueen GM, Grof P, Alda M, Marriott M, Young LT, Duffy A: A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord 2004;6:374–378.
  100. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillside, Erlbaum, 1988.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50